Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
crnx
/
Crinetics Pharmaceuticals Inc
CRNX
Add to Watchlist
83.865
USD
+0.135
+0.16%
Close 07-27 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/28, 09:30 (ET)
8.83B
Market Cap
Loss
P/E TTM
Crinetics Pharmaceuticals Inc
83.865
+0.135
+0.16%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
Other
61.10%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
Other
61.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.95%
Investment Advisor/Hedge Fund
40.84%
Hedge Fund
14.42%
Venture Capital
1.76%
Research Firm
1.71%
Individual Investor
1.57%
Private Equity
0.95%
Bank and Trust
0.58%
Pension Fund
0.40%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
556
115.89M
109.92%
-3.16M
2025Q4
525
110.25M
122.53%
+10.44K
2025Q3
543
110.25M
126.46%
+2.35M
2025Q2
527
106.83M
124.47%
+1.78M
2025Q1
508
105.21M
122.53%
-8.81M
2024Q4
492
102.43M
107.05%
+15.47M
2024Q3
460
87.33M
121.15%
+1.87M
2024Q2
441
84.74M
119.85%
+1.98M
2024Q1
399
82.75M
110.72%
-4.21M
2023Q4
366
73.18M
119.64%
+1.80M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
12.71M
12.14%
+175.28K
+1.40%
Dec 31, 2025
Wellington Management Company, LLP
8.04M
7.68%
-344.10K
-4.11%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.94M
6.63%
+290.48K
+4.37%
Dec 31, 2025
Farallon Capital Management, L.L.C.
6.93M
6.62%
+1.16M
+20.16%
Dec 31, 2025
Driehaus Capital Management, LLC
6.39M
6.1%
-93.87K
-1.45%
Dec 31, 2025
T. Rowe Price Associates, Inc.
5.12M
4.89%
-84.32K
-1.62%
Dec 31, 2025
Janus Henderson Investors
4.44M
4.24%
+581.90K
+15.08%
Dec 31, 2025
EcoR1 Capital, LLC
4.29M
4.1%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Pharmaceuticals ETF
3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.92%
Tema Heart & Health ETF
1.9%
ALPS Medical Breakthroughs ETF
1.79%
iShares U.S. Pharmaceuticals ETF
1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
1.31%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
ProShares Ultra Nasdaq Biotechnology
0.52%
Invesco Nasdaq Biotechnology ETF
0.4%
iShares Biotechnology ETF
0.34%
View more
State Street SPDR S&P Pharmaceuticals ETF
Proportion
3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
2.92%
Tema Heart & Health ETF
Proportion
1.9%
ALPS Medical Breakthroughs ETF
Proportion
1.79%
iShares U.S. Pharmaceuticals ETF
Proportion
1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion
1.31%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0.92%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.52%
Invesco Nasdaq Biotechnology ETF
Proportion
0.4%
iShares Biotechnology ETF
Proportion
0.34%